(Q37796023)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Imaging non-motor aspects of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Nicola Pavese

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

David J Brooks

series ordinal

1

1 reference

23 August 2017

Nicola Pavese

series ordinal

2

1 reference

23 August 2017

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

Progress in Brain Research

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

205-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Fatigue in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Stages in the development of Parkinson's disease-related pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Non-motor symptoms of Parkinson's disease: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Imaging amyloid deposition in Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Brain serotonin transporter binding in non-depressed patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Olfactory loss may be a first sign of idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Towards an understanding of fatigue in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

[18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Diurnal effects of motor activity and fatigue in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Controversies over the staging of alpha-synuclein pathology in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Fatigue in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Characteristics of orthostatic hypotension in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

FAST TRACK: daytime sleepiness in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Fatigue in levodopa-naive subjects with Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

Reduction of serotonin transporters of patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984011-7

7 January 2021

10.1016/S0079-6123(10)84011-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20887877%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference